• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

唐氏综合征患者痴呆的前瞻性 14 年纵向随访。

A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.

机构信息

School of Nursing & Midwifery, Trinity College Dublin, Dublin, Ireland.

出版信息

J Intellect Disabil Res. 2014 Jan;58(1):61-70. doi: 10.1111/jir.12074. Epub 2013 Jul 31.

DOI:10.1111/jir.12074
PMID:23902161
Abstract

BACKGROUND

To examine dementia characteristics, age at onset and associated comorbidities in persons with Down syndrome.

METHOD

Seventy-seven people with Down syndrome aged 35 years and older were followed longitudinally. The diagnosis of dementia was established using the modified International Classification of Diseases, Tenth Revision (ICD-10) criteria and a combination of objective and informant-based tests. Cognitive tests included the Test for Severe Impairment and the Down Syndrome Mental Status Examination; adaptive behaviour was measured using the Daily Living Skills Questionnaire. The Dementia Questionnaire for Mental Retarded Persons (DMR) was added to the test battery in 2005 and this study includes follow-up data for this instrument.

RESULTS

Over the 14-year period the average age of diagnosis at 55.41 years (SD = 7.14) was in the higher range of previously reported estimates (51-56 years) and a median survival of 7 years after diagnosis. Persons with dementia in the sample were significantly older than persons without dementia. The presence of dementia was also associated with epilepsy and sensory impairments. Among instruments the DMR appeared most sensitive to tracking change in symptoms over time before diagnosis.

CONCLUSION

The previously reported high risk levels for dementia among people with Down syndrome was confirmed in these data as was the value of the instruments utilised in tracking decline and helping to confirm diagnosis even in persons with severe intellectual disability.

摘要

背景

研究唐氏综合征患者痴呆的特征、发病年龄和相关合并症。

方法

对 77 名年龄在 35 岁及以上的唐氏综合征患者进行纵向随访。采用改良后的国际疾病分类第十版(ICD-10)标准和客观与信息源测试相结合的方法诊断痴呆。认知测试包括严重损害测试和唐氏综合征精神状态检查;采用日常生活技能问卷测量适应行为。2005 年,在测试组合中加入了智障人士痴呆问卷(DMR),本研究包括该测试工具的随访数据。

结果

在 14 年的时间里,平均诊断年龄为 55.41 岁(SD=7.14),处于先前报告的估计值(51-56 岁)的较高范围,且诊断后中位生存时间为 7 年。样本中痴呆患者的年龄明显大于非痴呆患者。痴呆的存在也与癫痫和感觉障碍有关。在这些工具中,DMR 似乎在诊断前跟踪症状变化方面最敏感。

结论

这些数据证实了唐氏综合征患者痴呆风险高的先前报告,也证实了在跟踪衰退和帮助确诊,甚至在智力严重残疾患者中,使用这些工具的价值。

相似文献

1
A prospective 14-year longitudinal follow-up of dementia in persons with Down syndrome.唐氏综合征患者痴呆的前瞻性 14 年纵向随访。
J Intellect Disabil Res. 2014 Jan;58(1):61-70. doi: 10.1111/jir.12074. Epub 2013 Jul 31.
2
A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome.唐氏综合征患者痴呆的前瞻性 20 年纵向随访。
J Intellect Disabil Res. 2017 Sep;61(9):843-852. doi: 10.1111/jir.12390. Epub 2017 Jun 29.
3
Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology.92例住院唐氏综合征成年患者的15年随访:认知功能衰退的发生率、与年龄的关系及神经病理学表现
J Intellect Disabil Res. 2007 Jun;51(Pt. 6):463-77. doi: 10.1111/j.1365-2788.2006.00902.x.
4
Survival in elderly persons with Down syndrome.唐氏综合征老年人的生存情况。
J Am Geriatr Soc. 2008 Dec;56(12):2311-6. doi: 10.1111/j.1532-5415.2008.01999.x.
5
The prevalence and incidence of mental ill-health in adults with Down syndrome.唐氏综合征成年患者心理健康问题的患病率和发病率。
J Intellect Disabil Res. 2008 Feb;52(Pt 2):141-55. doi: 10.1111/j.1365-2788.2007.00985.x.
6
The Adaptive Behaviour Dementia Questionnaire (ABDQ): screening questionnaire for dementia in Alzheimer's disease in adults with Down syndrome.适应性行为痴呆问卷(ABDQ):唐氏综合征成年患者阿尔茨海默病痴呆筛查问卷。
Res Dev Disabil. 2004 Jul-Aug;25(4):385-97. doi: 10.1016/j.ridd.2003.12.002.
7
Association of Dementia With Mortality Among Adults With Down Syndrome Older Than 35 Years.35 岁以上唐氏综合征患者痴呆与死亡率的相关性。
JAMA Neurol. 2019 Feb 1;76(2):152-160. doi: 10.1001/jamaneurol.2018.3616.
8
Early age at menopause is associated with increased risk of dementia and mortality in women with Down syndrome.早绝经与唐氏综合征女性痴呆和死亡风险增加有关。
J Alzheimers Dis. 2010;19(2):545-50. doi: 10.3233/JAD-2010-1247.
9
Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.抑郁症状、血管疾病与轻度认知障碍:心血管健康研究的结果
Arch Gen Psychiatry. 2006 Mar;63(3):273-9. doi: 10.1001/archpsyc.63.3.273.
10
Diagnostic instruments for dementia in older people with intellectual disability in clinical practice.临床实践中针对智障老年人的痴呆诊断工具。
Aging Ment Health. 2003 Nov;7(6):431-7. doi: 10.1080/13607860310001594682.

引用本文的文献

1
Investment in Alzheimer's disease research for the next generation of adults with Down syndrome will yield health benefits for future generations.对下一代唐氏综合征成年患者的阿尔茨海默病研究进行投资,将为子孙后代带来健康益处。
Alzheimers Dement. 2025 Sep;21(9):e70348. doi: 10.1002/alz.70348.
2
Physical activity as a resistance or resilience mechanism in Down syndrome Alzheimer's disease.体育活动作为唐氏综合征阿尔茨海默病的一种抵抗或恢复机制。
Alzheimers Dement (N Y). 2025 Jun 27;11(3):e70127. doi: 10.1002/trc2.70127. eCollection 2025 Jul-Sep.
3
Longitudinal investigation of gait and Alzheimer's disease in adults with Down syndrome.
唐氏综合征成人步态与阿尔茨海默病的纵向研究。
Alzheimers Dement. 2025 Apr;21(4):e70211. doi: 10.1002/alz.70211.
4
Enduring differential patterns of neuronal loss and myelination along 6-month pulsatile gonadotropin-releasing hormone therapy in individuals with Down syndrome.唐氏综合征患者在6个月脉冲式促性腺激素释放激素治疗期间神经元丢失和髓鞘形成的持续差异模式。
Brain Commun. 2025 Mar 22;7(2):fcaf117. doi: 10.1093/braincomms/fcaf117. eCollection 2025.
5
A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials.用于唐氏综合征临床试验的多种淀粉样蛋白PET放射性示踪剂的直接比较。
medRxiv. 2025 Mar 19:2025.03.18.25324200. doi: 10.1101/2025.03.18.25324200.
6
Validation of the CAMCOG-DS-II, a neuropsychological test battery for Alzheimer's disease in people with Down syndrome: A Horizon 21 European Down syndrome Consortium study.用于唐氏综合征患者的阿尔茨海默病神经心理测试组合CAMCOG-DS-II的验证:地平线21欧洲唐氏综合征联盟研究
Alzheimers Dement. 2025 Mar;21(3):e70071. doi: 10.1002/alz.70071.
7
Reduction of Cystatin B results in increased cathepsin B activity in disomic but not Trisomy 21 human cellular and mouse models.在二倍体而非21三体的人类细胞和小鼠模型中,胱抑素B的减少会导致组织蛋白酶B活性增加。
PLoS One. 2025 Jan 22;20(1):e0316822. doi: 10.1371/journal.pone.0316822. eCollection 2025.
8
Comparison between DSQIID total / sub-item scores and plasma p-tau elevation in adults with Down's syndrome.唐氏综合征成人患者DSQIID总分/子项得分与血浆p- tau升高情况的比较。
PLoS One. 2024 Dec 9;19(12):e0311878. doi: 10.1371/journal.pone.0311878. eCollection 2024.
9
In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline.进进出出:用于综合脑部疾病建模管道的体外、体内、离体和异种移植方法的基准测试。
Stem Cell Reports. 2024 Jun 11;19(6):767-795. doi: 10.1016/j.stemcr.2024.05.004.
10
Fine-Tuning Amyloid Precursor Protein Expression through Nonsense-Mediated mRNA Decay.通过无意义介导的 mRNA 衰减来精细调节淀粉样前体蛋白表达。
eNeuro. 2024 Jun 10;11(6). doi: 10.1523/ENEURO.0034-24.2024. Print 2024 Jun.